EP 1196567 A2 20020417 - HUMAN IMMUNE RESPONSE MOLECULES
Title (en)
HUMAN IMMUNE RESPONSE MOLECULES
Title (de)
MENSCHLICHE IMMUN ANTWORT GEBENDE MOLEKÜLE
Title (fr)
MOLECULES DE REPONSE IMMUNOLOGIQUE HUMAINES
Publication
Application
Priority
- US 0018505 W 20000706
- US 14257299 P 19990706
- US 15317099 P 19990909
Abstract (en)
[origin: WO0102569A2] The invention provides human immune response molecules (IMUN) and polynucleotides which identify and encode IMUN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of IMUN.
IPC 1-7
C12N 15/12; C07K 14/47; A01K 67/027; C07K 16/18; C12Q 1/68; A61K 38/17; G01N 33/50
IPC 8 full level
G01N 33/50 (2006.01); A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61P 1/04 (2006.01); A61P 1/16 (2006.01); A61P 1/18 (2006.01); A61P 3/10 (2006.01); A61P 5/14 (2006.01); A61P 7/00 (2006.01); A61P 7/04 (2006.01); A61P 7/06 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 13/00 (2006.01); A61P 13/12 (2006.01); A61P 17/02 (2006.01); A61P 17/06 (2006.01); A61P 17/12 (2006.01); A61P 19/02 (2006.01); A61P 19/06 (2006.01); A61P 19/08 (2006.01); A61P 19/10 (2006.01); A61P 21/04 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01); A61P 31/12 (2006.01); A61P 33/00 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 37/00 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/02 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01); G01N 37/00 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 1/16 (2017.12); A61P 1/18 (2017.12); A61P 3/10 (2017.12); A61P 5/14 (2017.12); A61P 7/00 (2017.12); A61P 7/04 (2017.12); A61P 7/06 (2017.12); A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 11/06 (2017.12); A61P 13/00 (2017.12); A61P 13/12 (2017.12); A61P 17/02 (2017.12); A61P 17/06 (2017.12); A61P 17/12 (2017.12); A61P 19/02 (2017.12); A61P 19/06 (2017.12); A61P 19/08 (2017.12); A61P 19/10 (2017.12); A61P 21/04 (2017.12); A61P 25/28 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 31/10 (2017.12); A61P 31/12 (2017.12); A61P 33/00 (2017.12); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 37/00 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C07K 14/47 (2013.01); A01K 2217/05 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 0102569A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0102569 A2 20010111; WO 0102569 A3 20010816; AU 6074000 A 20010122; CA 2378116 A1 20010111; EP 1196567 A2 20020417; JP 2003504024 A 20030204
DOCDB simple family (application)
US 0018505 W 20000706; AU 6074000 A 20000706; CA 2378116 A 20000706; EP 00947073 A 20000706; JP 2001508341 A 20000706